Dare Bioscience, Inc. (DARE) vs Vyome Holdings, Inc. (HIND)

Dare Bioscience, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Dare Bioscience, Inc. and Vyome Holdings, Inc. are of similar size ($14.5M and $14.5M). Dare Bioscience, Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against 103.8%. Dare Bioscience, Inc. has the higher net margin (−804.3% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Dare Bioscience, Inc. leads on 10 and Vyome Holdings, Inc. on 5.

Valuation

Metric DARE HIND Biotechnology median
P/E n/m 0.00 7.88
P/S 8.50 110.31 11.47
P/B n/m 1.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.07 n/m 0.74
EV/Sales (0.47) 78.55 10.73
Earnings yield (89.74%) 74,921.03% (28.84%)
Free cash flow yield (99.90%) (38.96%) (23.03%)

Profitability

Metric DARE HIND Biotechnology median
Gross margin 58.84% 52.77% 65.16%
Operating margin (813.35%) (9,184.82%) 0.00%
Net margin (804.33%) (8,711.71%) 0.00%
Free cash flow margin (849.36%) (4,298.00%) 0.00%
Return on equity 165.29% (172.10%) (57.72%)
Return on assets (62.16%) (124.23%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DARE HIND Biotechnology median
Revenue growth (TTM) 7,817.51% 103.81% 5.64%
EPS growth (last fiscal year) (150.00%) 99.92% —
Revenue growth, 5-year CAGR 66.71% (50.98%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DARE HIND Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.99 4.37 4.73
Net debt to EBITDA 2.07 0.48 0.96

Dividend

Metric DARE HIND Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DARE HIND Biotechnology median
Market cap 14.50m 14.46m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack